Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.25
+0.01000.81%
Post-market: 1.260.0100+0.80%19:52 EST
Volume:92.29K
Turnover:115.29K
Market Cap:13.27M
PE:-0.75
High:1.30
Open:1.28
Low:1.16
Close:1.24
52wk High:3.20
52wk Low:1.00
Shares:10.61M
Float Shares:4.05M
Volume Ratio:1.00
T/O Rate:2.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6599
EPS(LYR):-2.8960
ROE:-317.47%
ROA:-86.45%
PB:5.05
PE(LYR):-0.43

Loading ...

BioCardia Unveils Late-Breaking CardiAMP HF Trial Echocardiography Results at THT Meeting

Reuters
·
Feb 03

BioCardia Announces Late Breaking Echocardiography Results From the Cardiamp HF Trial to Be Presented at Technology and Heart Failure Therapeutics (Tht)

THOMSON REUTERS
·
Feb 03

BioCardia CEO Peter Altman Reports Disposal of Common Shares

Reuters
·
Jan 22

BioCardia CEO Peter Altman Reports Disposal of Common Shares

Reuters
·
Dec 18, 2025

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

GlobeNewswire
·
Dec 16, 2025

BioCardia Inc. Files Initial Beneficial Ownership Statement for Director Marvin Slosman

Reuters
·
Dec 11, 2025

BRIEF-Biocardia Announces Election Of New Board Director

Reuters
·
Dec 03, 2025

BioCardia Appoints Marvin Slosman to Board as Richard Krasno Departs

Reuters
·
Dec 03, 2025

Press Release: BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno

Dow Jones
·
Dec 03, 2025

BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress

GlobeNewswire
·
Dec 01, 2025

BioCardia Appoints New VP of Quality

TIPRANKS
·
Nov 25, 2025

BioCardia Strengthens Leadership Team With the Addition of Farhan Shahab as Vice President of Quality

THOMSON REUTERS
·
Nov 24, 2025

Press Release: BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality

Dow Jones
·
Nov 24, 2025

BioCardia, Inc. Q3 Net Income USD -1.483 Million

Reuters
·
Nov 20, 2025

BioCardia’s Earnings Call: Progress Amid Financial Challenges

TIPRANKS
·
Nov 14, 2025

BioCardia’s Q3 2025: Clinical Progress and Financial Stability

TIPRANKS
·
Nov 13, 2025

Cellular therapy developer BioCardia's Q3 net loss narrows

Reuters
·
Nov 13, 2025

BRIEF-BioCardia, Inc. Q3 Net Income USD -1.483 Million

Reuters
·
Nov 13, 2025

BioCardia, Inc. Q3 Operating Income USD -1.488 Million

THOMSON REUTERS
·
Nov 13, 2025

BioCardia, Inc. Q3 Basic EPS USD -0.24

THOMSON REUTERS
·
Nov 13, 2025